Literature DB >> 24266633

Impact of a hormone-releasing intrauterine system on the vaginal microbiome: a prospective baboon model.

S A Hashway1, I L Bergin, C M Bassis, M Uchihashi, K C Schmidt, V B Young, D M Aronoff, D L Patton, J D Bell.   

Abstract

BACKGROUND: Use of a levonorgestrel-releasing intrauterine system (LNG-IUS) in humans may alter vaginal microbial populations and susceptibility to pathogens. This study evaluated the time-dependent effects of an LNG-IUS on the vaginal microbiome of the baboon, a useful animal model for reproductive studies.
METHODS: Levonorgestrel-releasing intrauterine systems were inserted into three reproductively mature, female baboons. The animals were evaluated for 6 months by physical examination and Gram-stained cytology. The vaginal microbiota was characterized at each timepoint by culture-independent analysis of the 16S rRNA-encoding gene.
RESULTS: Each baboon harbored a diverse vaginal microbiome. Interindividual variation exceeded intra-individual variation. Diversity declined over time in one baboon and showed mild fluctuations in the other two. There were no significant community differences from early to late post-LNG-IUS placement.
CONCLUSIONS: The baboon vaginal microbiome is unique to each individual and is polymicrobial. In this pilot study, the vaginal microbiome remained stable from early to late post-LNG-IUS placement.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  levonorgestrel; non-human primate; pyrosequencing

Mesh:

Substances:

Year:  2013        PMID: 24266633      PMCID: PMC3954920          DOI: 10.1111/jmp.12090

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  40 in total

Review 1.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS).

Authors:  Trícia Lessard; José A Simões; Michelle G Discacciati; Margarete Hidalgo; Luis Bahamondes
Journal:  Contraception       Date:  2007-11-26       Impact factor: 3.375

3.  Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens.

Authors:  Charles R Wira; John V Fahey; Mimi Ghosh; Mickey V Patel; Danica K Hickey; Daniel O Ochiel
Journal:  Am J Reprod Immunol       Date:  2010-03-29       Impact factor: 3.886

4.  Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women.

Authors:  Sabina Cauci; Silvia Driussi; Davide De Santo; Paola Penacchioni; Teresa Iannicelli; Paolo Lanzafame; Francesco De Seta; Franco Quadrifoglio; Domenico de Aloysio; Secondo Guaschino
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

6.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.

Authors:  Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Daniel V Landers; Richard L Sweet
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

7.  [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].

Authors:  Seyda Calışkan; Sema Keçeli Özcan; Selvi Cınar; Aydın Corakçı; Eray Calışkan
Journal:  Mikrobiyol Bul       Date:  2011-10       Impact factor: 0.622

8.  Do Atopobium vaginae, Megasphaera sp. and Leptotrichia sp. change the local innate immune response and sialidase activity in bacterial vaginosis?

Authors:  Camila Marconi; Gilbert G Donders; Cristina M G L Parada; Paulo C Giraldo; Márcia Guimarães da Silva
Journal:  Sex Transm Infect       Date:  2012-10-16       Impact factor: 3.519

9.  Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods.

Authors:  Xia Zhou; Stephen J Bent; Maria G Schneider; Catherine C Davis; Mohammed R Islam; Larry J Forney
Journal:  Microbiology (Reading)       Date:  2004-08       Impact factor: 2.777

10.  Genomic sequence analysis and characterization of Sneathia amnii sp. nov.

Authors:  Michael D Harwich; Myrna G Serrano; Jennifer M Fettweis; João M P Alves; Mark A Reimers; Gregory A Buck; Kimberly K Jefferson
Journal:  BMC Genomics       Date:  2012-12-17       Impact factor: 3.969

View more
  14 in total

1.  Influence of age, reproductive cycling status, and menstruation on the vaginal microbiome in baboons (Papio anubis).

Authors:  M Uchihashi; I L Bergin; C M Bassis; S A Hashway; D Chai; J D Bell
Journal:  Am J Primatol       Date:  2015-02-12       Impact factor: 2.371

2.  Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.

Authors:  J Paul Brooks; David J Edwards; Diana L Blithe; Jennifer M Fettweis; Myrna G Serrano; Nihar U Sheth; Jerome F Strauss; Gregory A Buck; Kimberly K Jefferson
Journal:  Contraception       Date:  2016-11-29       Impact factor: 3.375

3.  Impact of the Levonorgestrel-Releasing Intrauterine System on the Progression of Chlamydia trachomatis Infection to Pelvic Inflammatory Disease in a Baboon Model.

Authors:  Alison J Eastman; Ingrid L Bergin; Daniel Chai; Christine M Bassis; William LeBar; George O Oluoch; Emma R Liechty; Atunga Nyachieo; Vincent B Young; David M Aronoff; Dorothy L Patton; Jason D Bell
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

4.  The levonorgestrel-releasing intrauterine system is associated with delayed endocervical clearance of Chlamydia trachomatis without alterations in vaginal microbiota.

Authors:  Emma R Liechty; Ingrid L Bergin; Christine M Bassis; Daniel Chai; William LeBar; Vincent B Young; Jason D Bell
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

Review 5.  The baboon (Papio sp.) as a model for female reproduction studies.

Authors:  Cassondra Bauer
Journal:  Contraception       Date:  2015-06-12       Impact factor: 3.375

6.  Primate vaginal microbiomes exhibit species specificity without universal Lactobacillus dominance.

Authors:  Suleyman Yildirim; Carl J Yeoman; Sarath Chandra Janga; Susan M Thomas; Mengfei Ho; Steven R Leigh; Bryan A White; Brenda A Wilson; Rebecca M Stumpf
Journal:  ISME J       Date:  2014-07-18       Impact factor: 10.302

7.  Repeated dose (28-day) administration of silver nanoparticles of varied size and coating does not significantly alter the indigenous murine gut microbiome.

Authors:  Laura A Wilding; Christine M Bassis; Kim Walacavage; Sara Hashway; Pascale R Leroueil; Masako Morishita; Andrew D Maynard; Martin A Philbert; Ingrid L Bergin
Journal:  Nanotoxicology       Date:  2015-11-02       Impact factor: 5.913

8.  Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals.

Authors:  Christine M Bassis; John R Erb-Downward; Robert P Dickson; Christine M Freeman; Thomas M Schmidt; Vincent B Young; James M Beck; Jeffrey L Curtis; Gary B Huffnagle
Journal:  MBio       Date:  2015-03-03       Impact factor: 7.867

9.  Recovery of the gut microbiome following fecal microbiota transplantation.

Authors:  Anna M Seekatz; Johannes Aas; Charles E Gessert; Timothy A Rubin; Daniel M Saman; Johan S Bakken; Vincent B Young
Journal:  MBio       Date:  2014-06-17       Impact factor: 7.867

10.  Vaginal Dysbiosis from an Evolutionary Perspective.

Authors:  Natalia Schlabritz-Loutsevitch; Scott E Gygax; Edward Dick; William L Smith; Cathy Snider; Gene Hubbard; Gary Ventolini
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.